Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Abstract

A comprehensive, unbiased inventory of synuclein forms present in Lewy bodies from patients with dementia with Lewy bodies was carried out using two-dimensional immunoblot analysis, novel sandwich enzyme-linked immunosorbent assays with modification-specific synuclein antibodies, and mass spectroscopy. The predominant modification of alpha-synuclein in Lewy bodies is a single phosphorylation at Ser-129. In addition, there is a set of characteristic modifications that are present to a lesser extent, including ubiquitination at Lys residues 12, 21, and 23 and specific truncations at Asp-115, Asp-119, Asn-122, Tyr-133, and Asp-135. No other modifications are detectable by tandem mass spectrometry mapping, except for a ubiquitous N-terminal acetylation. Small amounts of Ser-129 phosphorylated and Asp-119-truncated alpha-synuclein are present in the soluble fraction of both normal and disease brains, suggesting that these Lewy body-associated forms are produced during normal metabolism of alpha-synuclein. In contrast, ubiquitination is only detected in Lewy bodies and is primarily present on phosphorylated synuclein; it therefore likely occurs after phosphorylated synuclein has deposited into Lewy bodies. This invariant pattern of specific phosphorylation, truncation, and ubiquitination is also present in the detergent-insoluble fraction of brain from patients with familial Parkinson's disease (synuclein A53T mutation) as well as multiple system atrophy, suggesting a common pathogenic pathway for both genetic and sporadic Lewy body diseases. These observations are most consistent with a model in which preferential accumulation of normally produced Ser-129 phosphorylated alpha-synuclein is the key event responsible for the formation of Lewy bodies in various Lewy body diseases.

0500100020072008200920102011201220132014201520162017
Citations per Year

7,322 Citations

Semantic Scholar estimates that this publication has 7,322 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Anderson2006PhosphorylationOS, title={Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.}, author={John P. Anderson and Donald E. Walker and Jason M. Goldstein and Rian de Laat and Kelly J Banducci and Russell J. Caccavello and Robin M. Barbour and Jiping Huang and Kristin Kling and Michael Lee and Linnea Diep and Pamela S Keim and Xiaofeng Shen and T Chataway and Michael G. Schlossmacher and Peter Seubert and Dale B. Schenk and Sukanto Sinha and Wei Ping Gai and Tamie J. Chilcote}, journal={The Journal of biological chemistry}, year={2006}, volume={281 40}, pages={29739-52} }